Christele Semaille, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 234 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-9296 Fax: 505-747-7968 |
Dr. Guruchander Singh Khalsa, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 415 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-3369 Fax: 505-753-4006 |
Grd Health Clinic Inc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 415 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-3369 Fax: 505-753-4006 |
Dr. Salim Bohsali, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 234 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-9296 Fax: 505-747-7968 |
Dr. Damien Salvatore Passalacqua, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 82 County Road 122 # A, Espanola, NM 87532 Phone: 505-753-7576 |
Dr. Sat Siri K Khalsa, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 509 W Pueblo Dr, Espanola, NM 87532 Phone: 505-753-5640 |
Bodywise Health Center Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 234 N Paseo De Onate, Espanola, NM 87532 Phone: 505-753-9296 Fax: 505-747-7968 |
News Archive
Slowing or preventing the development of Alzheimer's disease, a fatal brain condition expected to hit one in 85 people globally by 2050, may be as simple as ensuring a brain protein's sugar levels are maintained.
Alcohol related hospitalisation is associated with a doubled risk of ischaemic stroke risk in patients with non-valvular atrial fibrillation, according to a study presented at ESC Congress 2016 today by Dr Faris Al-Khalili, cardiologist, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.
A selection of health policy stories from Virginia, California, Colorado, Missouri, Pennsylvania, Kansas and Texas.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today participated in the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Further to a Letter of Intent previously reported, Genesis Bioventures today announced that it has entered into a binding agreement with Efoora Inc. and Prion Developmental Laboratories, Inc. to buy all of Efoora's majority interest shares owned or pledged in PDL thereby gaining controlling interest of PDL. A Form 8-K has been filed with the SEC in this regard. Prior to the Agreement, GBI had one-third equity interest in PDL.
› Verified 7 days ago